ArticleiScience2024

Systematic omics analysis identifies CCR6 as a therapeutic target to overcome cancer resistance to EGFR inhibitors.

Eun-Ji Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.